Product Comparison


  Pfizer Biosimilar 00069029201 Amneal Pharmaceuticals LLC 70121169402 Pfizer Biosimilar 00069029101

No Image

No Image

McKesson # 1155120 1236824 1155119 1140103 1106376
Description Nivestym® Filgrastim-aafi 480 mcg / 0.8 mL Injection 0.8 mL Plerixafor 20 mg / mL Injection 1.2 mL Nivestym® Filgrastim-aafi 300 mcg / 0.5 mL Injection 0.5 mL Zarxio® Filgrastim-sndz 480 mcg / 0.8 mL Injection 0.8 mL Zarxio® Filgrastim-sndz 480 mcg / 0.8 mL Injection 0.8 mL
Manufacturer # 0006902920170121169402000690291016131403261061314032601
Brand Nivestym® Nivestym®Zarxio®Zarxio®
Manufacturer Pfizer BiosimilarAmneal Pharmaceuticals LLCPfizer BiosimilarSandozSandoz
Invoice NIVESTYM, PFS 480MCG/0.8MLPLERIXAFOR, SDV 20MG/ML 1.2MLNIVESTYM, PFS 300MCG/0.5MLZARXIO, PFS 480MCG/0.8ML (10/CT)ZARXIO, PFS 480MCG/0.8ML
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 2549681254961637968283796794
Container Type Prefilled SyringeSingle-Dose VialPrefilled SyringePrefilled SyringePrefilled Syringe
Generic Drug Code 4510416124451033808238082
Generic Drug Name Filgrastim-aafiPlerixaforFilgrastim-aafiFilgrastim-sndzFilgrastim-sndz
NDC Number 0006902920170121169402000690291016131403261061314032601
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
Strength 480 mcg / 0.8 mL20 mg / mL300 mcg / 0.5 mL480 mcg / 0.8 mL480 mcg / 0.8 mL
Type Intravenous or SubcutaneousSubcutaneousIntravenous or Subcutaneous
UNSPSC Code 5120180251131520512018025120180251201802
Volume 0.8 mL1.2 mL0.5 mL0.8 mL0.8 mL
Application Hematopoietic AgentHematopoietic AgentHematopoietic AgentHematopoietic AgentHematopoietic Agent
Country of Origin UnknownUnknownUnknownUnknownUnknown
Dosage Form InjectionInjectionInjectionInjectionInjection
Features and Benefits
  • Plerixafor injection, a hematopoietic stem cell mobilizer, is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma or multiple myeloma